|
Volumn 36, Issue 7, 2004, Pages 2175-2177
|
Excellent outcome of ABO-incompatible living kidney transplantation under pretransplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroid
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
ACUTE GRAFT REJECTION;
ADULT;
BLOOD GROUP ABO INCOMPATIBILITY;
CLINICAL ARTICLE;
CLINICAL OBSERVATION;
CONFERENCE PAPER;
CONTROLLED STUDY;
DISEASE SEVERITY;
FEMALE;
GRAFT SURVIVAL;
HUMAN;
HUMORAL IMMUNITY;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
INFECTION;
KIDNEY TRANSPLANTATION;
LETHALITY;
LIVING DONOR;
MALE;
PANCREATITIS;
PLASMAPHERESIS;
PREOPERATIVE CARE;
PRIORITY JOURNAL;
SPLENECTOMY;
SURGICAL PATIENT;
SURVIVAL RATE;
TREATMENT OUTCOME;
ABO BLOOD-GROUP SYSTEM;
ADRENAL CORTEX HORMONES;
ADULT;
BLOOD GROUP INCOMPATIBILITY;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
MALE;
MYCOPHENOLIC ACID;
PARENTS;
PREOPERATIVE CARE;
RETROSPECTIVE STUDIES;
SIBLINGS;
SPOUSES;
TACROLIMUS;
|
EID: 7044227643
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.08.142 Document Type: Conference Paper |
Times cited : (27)
|
References (2)
|